Kanjinti 55513-0141
Generic: Trastuzumab-Anns
Product NDC
55513-0141- Manufacturer
- Amgen, Inc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 28, 2019
- Listing Expires
- December 31, 2027
- Application
- BLA761073
Need to source Kanjinti? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Trastuzumab | 150 mg/7.15mL |
Drug Class
HER2/neu Receptor Antagonist [EPC]HER2/Neu/cerbB2 Antagonists [MoA]HER2/neu Receptor Antagonist [EPC]
Packaging Options(2)
1 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-01) / 7.15 mL in 1 VIAL, SINGLE-DOSE
1 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-21) / 7.15 mL in 1 VIAL, SINGLE-DOSE